Menu Search
Equities

Scandinavian Medical Solutions A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
K41:FRA

Scandinavian Medical Solutions A/S

Actions
  • Price (EUR)0.476
  • Today's Change0.000 / 0.00%
  • Shares traded100.00
  • 1 Year change-31.81%
  • Beta0.7724
Data delayed at least 15 minutes, as of Feb 16 2026 14:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Scandinavian Medical Solutions A/S is a Denmark-based supplier of used diagnostic imaging equipment that enables healthcare personnel and healthcare organizations to deliver better and more cost-effective healthcare services. The Company's offering includes Magnetic Resonance Imaging (MRI) devices, devices for ultrasound scanning, linear accelerators and mammograms, among others. Scandinavian Medical Solutions offers a complete business to business solution which includes the transport of the ton-heavy sensitive machines to hospitals. The Company's goal is to be the first independent European full-service provider of all integrated services for imaging equipment such as rental, sale of spare parts and installation of systems.

  • Revenue in DKK (TTM)245.44m
  • Net income in DKK26.00k
  • Incorporated2018
  • Employees28.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.